Latest Whitepapers
Whitepaper
Novel Technology Expands the Power of DIA-MS
Download this whitepaper to review the exciting technology behind the advances in data independent acquisition and explore how it can enhance your research.
Whitepaper
Metabolic Phenotyping to Assess Mitochondrial Toxicity
This whitepaper highlights the key principles of mitochondrial toxicity assessment during drug discovery. It features customized assay solutions and the latest cell energy phenotyping technology.
Whitepaper
Batch-to-Batch Consistency of Premium Grade Bioactive Proteins
Many novel cell and gene therapies have the potential to offer personalized therapeutic approaches and hold great promise for curing or treating diseases.
Whitepaper
Cell Painting – Phenotypic Drug Discovery Re-Imagined
Cell Painting is a multistep process, in which different compartments of cells are labeled with various fluorescent bioprobes to quantitatively profile multiple phenotypic parameters to better understand the effects of chemical compounds, drugs, genes, or other test articles.
Whitepaper
The Battle Against COVID-19
The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?
Whitepaper
COVID-19 and Organoids: Mini Organs With Massive Potential
Download your whitepaper to learn more about modeling COVID-19 infection in organoids, how to combat COVID-19 variants as well as the future of organoid technology.
Whitepaper
Considerations for Efficient Scale-Up of PSCs in Suspension Culture
Download this whitepaper to discover scale-up considerations such as suspension culture passaging strategies, medium exchange strategies plus suspension culture seeding density.
Whitepaper
Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome
Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others.
Whitepaper
Autologous CAR T-Cell Manufacturing
Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.
Whitepaper
Challenging Host Cell Protein Assays for Improved Risk Mitigation
At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.
Advertisement